Drucken
Artikel, Notizen und Markierungen werden geladen... Bitte um etwas Geduld.

Federal Act
on Medicinal Products and Medical Devices
(Therapeutic Products Act, TPA)

Art. 15 Marketing authorisation on the basis of a notification 59

1 The fol­low­ing may be placed on the mar­ket fol­low­ing no­ti­fic­a­tion to the Agency:

a.
com­ple­ment­ary medi­cines without in­dic­a­tions, the act­ive sub­stances of which are in­cluded in lists for spe­cif­ic ther­apy ap­proaches;
b.
oth­er medi­cin­al products or groups of medi­cin­al products for which, due to their low risk po­ten­tial, a sim­pli­fied mar­ket­ing au­thor­isa­tion proves to be dis­pro­por­tion­ate.

2 The Agency shall draw up the lists re­ferred to in para­graph 1 let­ter a. It shall de­term­ine the medi­cin­al products or groups of medi­cin­al products re­ferred to in para­graph 1 let­ter b and reg­u­late the no­ti­fic­a­tion pro­ced­ure.

59 Amended by No I of the FA of 18 March 2016, in force since 1 Jan. 2019 (AS 2017 2745, 2018 3575; BBl 2013 1).